EUVIMEDEUVIMED entdecken
Open Access

Blocking IL-17a Signaling Decreases Lung Inflammation and Improves Alveolarization in Experimental Bronchopulmonary Dysplasia

Meagan Goates, Amrit Shrestha, Shyam Thapa, Matthew Bettini, Roberto Barrios, Binoy Shivanna

The American Journal of Pathology · 2024

DOI: 10.1016/j.ajpath.2024.07.011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The American Journal of Pathology, 2024. Verfasst von Meagan Goates und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neonatology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas. Hauptthemen laut MEDLINE: Bronchopulmonary Dysplasia, Interleukin-17, Signal Transduction, Lipopolysaccharides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NICHD NIH HHS, Baylor College of Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bronchopulmonary dysplasia (BPD) is the most common chronic lung disease of preterm infants that is associated with life-long morbidities. Inflammatory insults contribute to BPD pathogenesis. Although the proinflammatory cytokine, IL-17a, plays a role in various neonatal inflammatory disorders, its role in BPD pathogenesis is unclear. To test the hypothesis that blocking IL-17a signaling decreases lipopolysaccharide (LPS)-mediated experimental BPD in neonatal mice, wild-type mice were injected intraperitoneally with phosphate-buffered saline or LPS during the saccular lung developmental phase. Pulmonary IL-17a expression was determined by enzyme-linked immunosorbent assay and by flow cytometry. LPS-injected mice had higher pulmonary IL-17a protein levels and IL-17a+ and IL-22+ cells. γδ T cells, followed by non-T lymphoid cells, were the primary producers of IL-17a. Wild-type mice were then injected intraperitoneally with isotype antibody (Ab) or IL-17a Ab, while they were treated with phosphate-buffered saline or LPS, followed by quantification of lung inflammatory markers, alveolarization, vascularization, cell proliferation, and apoptosis. LPS-mediated alveolar simplification, apoptosis, and cell proliferation inhibition were significantly greater in mice treated with isotype Ab than in those treated with IL-17a Ab. Furthermore, STAT1 activation and IL-6 levels were significantly greater in LPS-exposed mice treated with isotype Ab than in those treated with IL-17a Ab. The study results indicate that blocking IL-17a signaling decreases LPS-mediated experimental BPD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bronchopulmonary DysplasiaInterleukin-17Signal TransductionLipopolysaccharidesAnimalsMicePneumoniaPulmonary AlveoliMice, Inbred C57BLDisease Models, AnimalAnimals, NewbornApoptosisCell Proliferation

Substanzen

Interleukin-17LipopolysaccharidesIl17a protein, mouse

Autor:innen und Institutionen

  • Division of Neonatology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.
  • Department of Microbiology and Immunology, University of Utah, Salt Lake City, Utah.
  • Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas.
  • Division of Neonatology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas. Electronic address: shivanna@bcm.edu.

Förderung

  • NHLBI NIH HHS
  • NICHD NIH HHS
  • Baylor College of Medicine
  • National Institutes of Health
  • American Academy of Pediatrics

Zitieren

APA

Goates, M., Shrestha, A., Thapa, S., Bettini, M., Barrios, R., & Shivanna, B. (2024). Blocking IL-17a Signaling Decreases Lung Inflammation and Improves Alveolarization in Experimental Bronchopulmonary Dysplasia. The American Journal of Pathology. https://doi.org/10.1016/j.ajpath.2024.07.011

Vancouver

Goates M, Shrestha A, Thapa S, Bettini M, Barrios R, Shivanna B. Blocking IL-17a Signaling Decreases Lung Inflammation and Improves Alveolarization in Experimental Bronchopulmonary Dysplasia. The American Journal of Pathology. 2024. doi:10.1016/j.ajpath.2024.07.011

BibTeX
@article{Goates2024,
  author = {Goates, Meagan and Shrestha, Amrit and Thapa, Shyam and Bettini, Matthew and Barrios, Roberto and Shivanna, Binoy},
  title = {Blocking IL-17a Signaling Decreases Lung Inflammation and Improves Alveolarization in Experimental Bronchopulmonary Dysplasia},
  journal = {The American Journal of Pathology},
  year = {2024},
  doi = {10.1016/j.ajpath.2024.07.011}
}
Kostenlos starten →